A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.
Clinical trial NCT00158860 · COMPLETED
Trial details
- NCT number
- NCT00158860
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-21
- Primary completion
- 2006-07-26
- Enrollment
- 384
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.